Yinghe Technology: No Plans for Domestic E-Cigarette Sales; MEMERS and VFLY Focus on the US Market

Jan.21
Yinghe Technology: No Plans for Domestic E-Cigarette Sales; MEMERS and VFLY Focus on the US Market
Investor inquiries prompt Yinghe Technology to confirm subsidiary Sikary has obtained e-cigarette production license, focusing on overseas market.

Recently, an investor on an interactive platform asked Yinghe Technology (300457.SZ) whether its subsidiary Sikary has obtained the production and sales license from the State Tobacco Monopoly Administration, and if the company plans to sell e-cigarettes domestically.


In response, Yinghe Technology stated that its subsidiary Sikary has obtained the Tobacco Monopoly Administration's "Tobacco Monopoly production enterprise license" (for e-cigarette production enterprises). Currently, Sikary's e-cigarette products are all exported, primarily to overseas markets, and the company does not currently have any plans for domestic sales.


In addition, the company revealed that Sikary's experience store opened in the UK in 2024 has officially started operating and is performing well. Its e-cigarette brands MEMERS and VFLY are focused on promoting and selling products in the US market.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders
Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders
Social media users reported purchasing Altria’s new nicotine pouch, on!PLUS, in the United States. 2Firsts found that the official on! website had temporarily opened online purchase and store locator functions. The product has not received FDA authorization. Around the same time, British American Tobacco (BAT) suspended its unlicensed Vuse One vape launch in the U.S. amid regulatory pressure.
Oct.28 by 2FIRSTS.ai
Spanish Police Seize Over 24,000 Smuggled E-Cigarettes; Two Arrested on Multiple Charges
Spanish Police Seize Over 24,000 Smuggled E-Cigarettes; Two Arrested on Multiple Charges
The Spanish Civil Guard carried out an operation targeting e-cigarette smuggling and illegal distribution, seizing a total of 24,520 e-cigarettes of unknown origin valued at approximately €312,000.
Oct.10 by 2FIRSTS.ai
BAT Podcast with AACS CEO: Vape Policy Imbalance Fuels Australia’s Billion-Dollar Illicit Market
BAT Podcast with AACS CEO: Vape Policy Imbalance Fuels Australia’s Billion-Dollar Illicit Market
In BAT’s The Smokeless Word podcast, AACS CEO Theo Foukkare warned that high taxes and strict vape bans have fueled Australia’s AUD 10-billion illicit nicotine market and rising retail crime, urging urgent regulatory reform.
Oct.27 by 2FIRSTS.ai
Belarus Proposes 20% Tax Increase on Vaping Products and Nicotine Items
Belarus Proposes 20% Tax Increase on Vaping Products and Nicotine Items
Belarus will increase excise taxes in 2026 on vapes, liquids for electronic smoking systems, and non-tobacco nicotine products, with a proposed 20% rise aimed at aligning these rates with traditional cigarettes. Electronic smoking devices and heated tobacco systems will also be added to the list of excisable goods. Excise taxes on filtered cigarettes and heated tobacco will rise by 7% and 3% respectively.
Nov.13 by 2FIRSTS.ai
Leaked EU Paper Suggests COP11 Push to Ban Nicotine Pouches and Flavoured Nicotine Products
Leaked EU Paper Suggests COP11 Push to Ban Nicotine Pouches and Flavoured Nicotine Products
According to media reports, a leaked European Commission document indicates the EU plans to push for its strictest regulatory framework on nicotine and tobacco products at COP11 in Switzerland this November, including measures such as a full ban on nicotine pouches and flavoured products.
Oct.10 by 2FIRSTS.ai
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.
Oct.10